Mochi vs. Luma Health: Compounded GLP-1 Clinic Comparison
If you're comparing Mochi to a compounded GLP-1 clinic like Luma Health, you're likely weighing two fairly different business models rather than two similar products with different logos. Mochi built its reputation around a membership-plus-medication structure aimed heavily at women navigating hormonal shifts in their 40s, 50s, and beyond — pairing semaglutide access with broader women's health positioning. Luma Health takes a narrower, more transactional approach: a single flat monthly rate for semaglutide or tirzepatide, with a named compounding pharmacy and no separate membership tier. Neither structure is universally "better." What matters is which one actually fits how you want to pay, how much hand-holding you want, and how long you plan to stay on treatment.
What This Comparison Actually Covers
Readers searching for a Mochi comparison are usually not deciding between brand names in the abstract — they're trying to figure out whether Mochi's membership fee is worth it, whether a straight compounding pharmacy model like Luma Health's is simpler, and whether tirzepatide is even meaningfully available through Mochi at all. This page walks through pricing structure, pharmacy transparency, dose flexibility, and the practical realities of switching providers if your first choice doesn't work out.
Quick Answer
Mochi's model bundles a recurring membership fee (roughly $35–$79/month) on top of medication cost (around $135/month for semaglutide), pushing effective monthly cost into the $214–$258 range depending on plan tier. Luma Health charges $197/month flat for semaglutide or $297/month flat for tirzepatide — no separate membership layer, no dose-tier pricing changes, and a named 503A compounding pharmacy (VialsRX, Texas Board #35264) disclosed up front. If you want fewer moving parts in your monthly bill and clear tirzepatide access, Luma Health's flat-rate structure is usually easier to reason about. If you specifically want Mochi's hormonal-health-adjacent coaching and community positioning, that's a real reason to stay with Mochi.
Pricing Structure: Membership Model vs. Flat Rate
The biggest structural difference between these two providers is how the bill is assembled. Mochi's published pricing separates a membership fee from the medication cost itself — reporting suggests a membership layer somewhere in the $35–$79/month range stacked on top of a semaglutide price around $135/month, which lands the effective all-in cost somewhere between roughly $214 and $258 per month depending on which membership tier a patient selects. That structure means the sticker price for the medication alone understates what you'll actually pay, and it also means your monthly total can shift if you upgrade or downgrade your membership tier independent of any change in your prescription.
Luma Health's pricing removes that second layer entirely. Semaglutide is $197/month flat, tirzepatide is $297/month flat, and that price does not change based on dose within the prescribed course of treatment. There's no separate membership fee, no coaching-tier upsell, and no dose-based price ladder to track. For patients who've been burned before by a provider whose "starting at" price ballooned once fees were added, a single flat number is often easier to budget around, even when the headline number looks higher at first glance.
It's worth being honest about where this cuts the other way, too. On a pure semaglutide comparison, Mochi's medication-only cost of roughly $135/month is lower than Luma Health's $197/month — the gap only closes once Mochi's membership fee is added back in. If a patient can get by on the lowest membership tier and doesn't need the coaching layer, Mochi's effective cost could land close to or even under Luma Health's rate. That's a legitimate reason some readers should stay with Mochi rather than switch.
| Cost factor | Mochi | Luma Health |
|---|---|---|
| Semaglutide, medication only | ~$135/mo | $197/mo (includes everything) |
| Membership/platform fee | ~$35–$79/mo, tiered | None |
| Effective semaglutide total | ~$214–$258/mo | $197/mo flat |
| Tirzepatide pricing | Not consistently published — verify directly with Mochi | $297/mo flat, all doses |
| Price changes by dose | Membership tier can shift cost independent of dose | No — flat regardless of prescribed dose |
| Enrollment/consultation fee | Not clearly separated from membership | None |
Pharmacy Transparency
Before paying any GLP-1 provider, it's worth knowing exactly which pharmacy is compounding your prescription and whether that pharmacy's license is independently verifiable. This is one of the areas where compounded-GLP-1 providers vary the most, and it's not always obvious from a provider's marketing pages.
Luma Health names its compounding partner directly: VialsRX, a 503A community sterile compounding pharmacy licensed by the Texas State Board of Pharmacy under license #35264, operating under Section 503A of the Federal Food, Drug, and Cosmetic Act. That license number can be verified independently at pharmacy.texas.gov before any payment is made. Mochi, like several telehealth competitors in this space, does not prominently name its compounding pharmacy partner on public-facing pages — patients who want that information typically need to contact Mochi support directly to obtain it. Neither situation is necessarily disqualifying, but a named, independently verifiable license is a meaningfully lower-friction way to confirm legitimacy than having to ask.
| Provider | Pharmacy disclosure |
|---|---|
| Luma Health | VialsRX, TX Board #35264 — named, verifiable at pharmacy.texas.gov before payment |
| Mochi | Not prominently named on public pages — contact support to obtain |
Dose Flexibility and Medication Access
Semaglutide and tirzepatide are both dosed on an escalating schedule, starting low and increasing over weeks or months as tolerated. How a provider prices across that titration schedule matters more than the entry-level number most marketing pages lead with. Luma Health's flat-rate structure means a patient starting at a low dose and a patient who has titrated up to a therapeutic maintenance dose pay the same $197 or $297 per month — there's no separate charge as the prescribed dose increases, which removes a common source of bill-shock later in treatment.
Mochi's medication pricing appears to follow a similar flat structure at the semaglutide level, but the added membership tiers introduce a second variable that can move independently of dose. A patient might see their monthly total change not because their prescription changed, but because they moved between membership tiers for coaching or support features. For tirzepatide specifically, Mochi's public pricing is less consistently documented than its semaglutide pricing, so anyone specifically wanting tirzepatide through Mochi should confirm current availability and cost directly with Mochi before assuming pricing parity with their semaglutide plan.
Long-Term Cost Math
Over a full year of treatment, the gap between a $35 and $79 monthly membership tier compounds meaningfully. At the lower Mochi membership tier, a year of semaglutide runs approximately $2,568 (about $214/month × 12). At the higher tier, that same year of treatment runs closer to $3,096 (about $258/month × 12). Luma Health's flat $197/month semaglutide plan totals $2,364 annually — below Mochi's lower-tier estimate and meaningfully below its upper tier. For tirzepatide, Luma Health's $297/month plan totals $3,564 per year; because Mochi does not consistently publish tirzepatide pricing, a direct annual comparison isn't currently possible without contacting Mochi for a current quote.
| 12-month total (semaglutide) | Mochi | Luma Health |
|---|---|---|
| Lower membership tier | ~$2,568/yr | $2,364/yr |
| Upper membership tier | ~$3,096/yr | $2,364/yr |
Pros and Cons
Mochi — Strengths
- Established brand positioning around women's hormonal health and midlife weight management
- Lower base medication-only price for semaglutide before membership fee is added
- Membership tiers may include coaching or community features some patients value
Mochi — Watch-outs
- Effective monthly cost is higher than headline price once membership fee is included
- Compounding pharmacy identity not prominently disclosed publicly
- Tirzepatide pricing and availability not consistently published
Who May Prefer Mochi
Mochi may be right for you if:
- You already trust the Mochi brand or have used it before
- You specifically want the coaching or community layer bundled with treatment
- You're comfortable confirming pharmacy and tirzepatide details directly with support
- You're only pursuing semaglutide and can use a lower membership tier
Luma Health may be right for you if:
- You want one flat monthly number with no separate membership fee
- You want a named, independently verifiable compounding pharmacy up front
- You're specifically interested in tirzepatide with clearly published pricing
- You've moved between doses before and don't want your bill to change because of it
Switching Considerations
If you're currently on Mochi and considering a switch, the practical steps are straightforward: request your current dose and prescription history from Mochi, complete Luma Health's online intake and clinician evaluation, and confirm your new prescription is written to continue at a clinically appropriate dose rather than restarting from the lowest titration step unnecessarily. Most patients switching between compounded GLP-1 providers can maintain dose continuity as long as their new clinician has an accurate record of their current regimen and tolerability history. It's worth asking any new provider — Luma Health included — how they handle dose continuity for patients transferring from another compounded program before you cancel your existing membership.
Frequently Asked Questions
Is Mochi more expensive than Luma Health?
It depends on which membership tier you'd select and which medication you need. On semaglutide alone, Mochi's medication-only price (~$135/month) is lower than Luma Health's flat $197/month, but once Mochi's membership fee (~$35–$79/month) is added, the effective total (~$214–$258/month) is typically higher than Luma Health's flat rate. For tirzepatide, a direct comparison isn't currently possible because Mochi doesn't consistently publish tirzepatide pricing.
Does Mochi disclose which pharmacy compounds its medication?
Mochi does not prominently name its compounding pharmacy partner on its public-facing pages. Patients who want to verify the pharmacy's license and standing typically need to contact Mochi support directly. Luma Health, by comparison, names VialsRX and its Texas Board license number (#35264) directly on its site, and that license can be verified independently at pharmacy.texas.gov.
Can I get tirzepatide through Mochi?
Tirzepatide availability and pricing through Mochi is not as consistently published as its semaglutide offering. If tirzepatide is your priority, it's worth confirming current availability, dosing options, and cost directly with Mochi before enrolling, or comparing against Luma Health's flat $297/month tirzepatide plan, which is published and consistent across all prescribed doses.
Why does Mochi charge a separate membership fee?
Mochi's membership fee appears to fund platform features beyond the prescription itself — potentially including coaching, community access, or app-based tracking tools, depending on the tier selected. Whether that's worth the added monthly cost depends on how much you value those features versus a simpler flat-rate structure like Luma Health's, which folds clinical support into the base price with no separate tier.
What happens to my cost if I change doses on Mochi versus Luma Health?
On Luma Health, your monthly price stays flat at $197 (semaglutide) or $297 (tirzepatide) regardless of which dose you're prescribed within your plan. On Mochi, the medication price appears flat as well, but your total bill can still shift if you move between membership tiers for reasons unrelated to your prescribed dose, which makes it harder to predict your cost purely from your treatment plan.
How do I switch from Mochi to Luma Health without losing progress?
Request your current dose history and any relevant lab or tolerability notes from Mochi, then complete Luma Health's online intake so a licensed clinician can review your history and continue your prescription at a clinically appropriate dose. Most patients can maintain continuity rather than restarting titration, provided the new clinician has accurate records of what you were previously prescribed and how you tolerated it.
Is Mochi a legitimate GLP-1 provider?
Mochi is an established telehealth brand with a public presence and marketing history, which is a reasonable starting signal of legitimacy. That said, the same verification standard applies to any provider: confirm which pharmacy is compounding your specific prescription and check that pharmacy's license with the relevant state board before paying. If that information isn't readily available on a provider's site, it's reasonable to ask support directly rather than assume.
Sources & References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384:989-1002. View on PubMed
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387:205-216. View on PubMed
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity Without Diabetes (SELECT). N Engl J Med. 2023;389:2221-2232. View on PubMed
- Perkovic V, Tuttle KR, Rossing P, et al. Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW). N Engl J Med. 2024;391:109-121. View on PubMed
- U.S. Food and Drug Administration. Human Drug Compounding and the FD&C Act. Read on FDA.gov
- Texas State Board of Pharmacy. License Verification. Verify at pharmacy.texas.gov
- National Association of Boards of Pharmacy. Compounding Pharmacy Accreditation. Read on NABP.pharmacy
- National Institute of Diabetes and Digestive and Kidney Diseases. Prescription Medications to Treat Overweight & Obesity. Read on NIDDK.nih.gov